Melatonin as a chronobiotic and cytoprotective agent in Parkinson’s disease
Abstract: This article discusses the role that melatonin may have in the prevention and treatment of Parkinson’s disease (PD). In parkinsonian patients circulating melatonin levels are consistently disrupted and the potential therapeutic value of melatonin on sleep disorders in PD was examined in...
Guardado en:
| Autores principales: | Pérez Lloret, Santiago, Cardinali, Daniel Pedro |
|---|---|
| Formato: | Artículo |
| Lenguaje: | Inglés |
| Publicado: |
Frontiers Media
2021
|
| Materias: | |
| Acceso en línea: | https://repositorio.uca.edu.ar/handle/123456789/11620 |
| Aporte de: |
Ejemplares similares
-
Melatonin as a chronobiotic and cytoprotective agent in Parkinson’s disease
por: Pérez Lloret, Santiago, et al.
Publicado: (2021) -
Melatonin : clinical perspectives in neurodegeneration
por: Cardinali, Daniel Pedro
Publicado: (2019) -
Therapeutical implications of melatonin in alzheimer’s and parkinson’s diseases
por: Cardinali, Daniel Pedro, et al.
Publicado: (2020) -
Pharmacotherapies for parkinson's disease symptoms related to cholinergic degeneration
por: Pérez Lloret, Santiago, et al.
Publicado: (2022) -
The renin–angiotensin system modulates dopaminergic neurotransmission : A new player on the scene
por: Kobiec, Tamara, et al.
Publicado: (2021)